Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.64 |
| ▸ | ERN1 | O75460 | 6/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5397554 | 0.78 | CYP2A6 (0.64) | CYP2A6ERN1KDM4EALDH1A1MAPT | |
| SCHEMBL3640233 | 0.78 | CYP2A6 (0.64) | CYP2A6ERN1MAPTTDP1 | |
| SCHEMBL7332731 | 0.78 | CYP2A6 (0.64) | CYP2A6ERN1MEN1ALDH1A1MAPT | |
| SCHEMBL2022637 | 0.78 | CYP2A6 (1.00) | CYP2A6ERN1ALDH1A1MAPT | |
| SCHEMBL29679015 | 0.78 | CYP2A6 (0.64) | CYP2A6ERN1MAPTTDP1 | |
| SCHEMBL16619089 | 0.74 | CYP2A6 (0.58) | CYP2A6ERN1KDM4EMEN1MAPT | |
| SCHEMBL4998343 | 0.74 | CYP2A6 (0.58) | CYP2A6ERN1KDM4EALDH1A1MAPT | |
| SCHEMBL20954434 | 0.74 | CYP2A6 (0.58) | CYP2A6ERN1KDM4EMEN1ALDH1A1 | |
| SCHEMBL20954428 | 0.74 | CYP2A6 (0.58) | CYP2A6ERN1 | |
| SCHEMBL17912645 | 0.74 | CYP2A6 (0.61) | CYP2A6ERN1KDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9993459-B2 | Selective HDAC6 inhibitors and uses thereof | UNIVERSITEIT GENT (BE) | 2018-06-12 | — | — | US | disclosed |
| US-20170360748-A1 | SELECTIVE HDAC6 INHIBITORS AND USES THEREOF | UNIVERSITEIT GENT (BE) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170360748-A1 | SELECTIVE HDAC6 INHIBITORS AND USES THEREOF | HDAC6, HDAC1, HDAC5 | CYP2A6 4402/4885ERN1 2959/4885PARP1 352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.